Skip to main content
. 2017 Nov 6;19(Suppl 5):v1–v88. doi: 10.1093/neuonc/nox158

Table 25.

One-, Two-, Five-, and Ten-Year Relative Survival Ratesa,b for Selected Non-Malignant Brain and Other Central Nervous System Tumors by NCI Age-Groups, SEER 18 Registries, 2004-2014c

Histology Age-Group (years) N d 1-Year 2-Year 5-Year 10-Year
% 95% CI % 95% CI % 95% CI % 95% CI
Unique astrocytoma variants Childrene (0-14) 134 97.7 92.7-99.3 97.7 92.7-99.3 97.7 92.7-99.3 96.6 67.6-97.2
AYAf (15-39) 91 96.6 89.5-98.9 96.6 89.5-98.9 90.7 80.9-95.6 80.1 55.2-92.1
Adults (40+) -- -- -- -- -- -- -- -- --
Ependymal tumors Childrene (0-14) 71 100.0 ** 98.3 87.5-99.8 93.8 81.5-98.0 93.8 81.5-98.0
AYAf (15-39) 470 99.7 97.9-99.9 98.8 97.4-99.8 98.6 95.9-99.5 98.2 95.1-99.4
Adults (40+) 958 96.8 95.1-97.9 96.6 94.6-97.8 96.5 94.2-97.9 94.2 85.3-97.8
Choroid plexus tumors Childrene (0-14) 159 98.9 94.2-99.8 98.1 93.4-99.5 95.3 89.3-98.0 95.3 89.3-98.0
AYAf (15-39) 127 98.4 93.4-99.6 98.4 93.4-99.6 97.6 91.7-99.3 97.6 91.7-99.3
Adults (40+) 142 83.0 75.2-88.6 81.5 73.1-87.6 76.5 66.2-84.1 75.7 64.6-83.7
Neuronal and mixed neuronal-glial tumors Childrene (0-14) 653 98.7 97.4-99.4 98.4 96.9-99.2 97.0 95.1-98.3 94.5 89.6-97.1
AYAf (15-39) 969 98.3 97.2-99.0 97.8 96.5-98.6 95.3 93.3-96.7 93.9 91.2-05.8
Adults (40+) 531 93.0 90.2-95.1 90.9 87.6-93.3 86.2 81.7-89.7 82.1 76.4-86.6
Nerve sheath tumors Childrene (0-14) 467 100.0 ** 100.0 ** 99.8 95.3-100.0 98.4 95.2-99.5
AYAf (15-39) 2,758 99.6 99.2-99.8 99.3 99.8-99.6 98.7 98.0-99.2 97.7 96.1-98.6
Adults (40+) 14,570 99.4 99.1-99.6 99.4 99.0-99.6 99.4 99.0-99.6 99.4 99.0-99.6
Meningioma Childrene (0-14) 148 97.9 93.4-99.3 97.1 92.2-98.9 97.1 92.2-98.9 97.1 92.2-98.9
AYAf (15-39) 4,906 98.8 98.4-99.1 98.3 97.9-98.7 96.7 96.0-97.3 94.2 92.8-95.4
Adults (40+) 70,171 92.0 91.8-92.3 90.0 89.7-90.3 86.0 85.5-86.4 80.4 79.5-81.3
Mesenchymal tumors Childrene (0-14) 165 99.5 92.2-100.0 98.6 93.2-99.7 96.8 88.3-99.2 93.9 81.4-98.1
AYAf (15-39) 152 97.9 93.4-99.4 97.9 93.4-99.4 94.3 86.4-97.7 87.7 74.3-94.3
Adults (40+) 378 95.7 92.5-97.6 95.0 91.2-97.2 90.5 84.6-94.2 73.9 58.9-84.1
Other neoplasms related to the meninges Childrene (0-14) -- -- -- -- -- -- -- -- --
AYAf (15-39) 544 97.3 95.5-98.5 96.8 94.7-98.0 95.9 93.5-97.4 92.5 88.0-95.4
Adults (40+) 1,094 94.6 92.8-95.9 93.6 91.5-95.2 89.9 86.9-92.3 86.6 80.8-90.8
Germ cell tumors, cysts and heterotopias Childrene (0-14) 90 94.0 85.9-97.5 94.0 85.9-97.5 94.0 85.9-97.5 94.0 85.9-97.5
AYAf (15-39) 89 98.9 91.1-99.9 96.3 88.2-98.9 96.3 88.2-98.9 96.3 88.2-98.9
Adults (40+) 86 91.3 81.6-96.0 91.3 81.6-96.0 91.3 81.6-96.0 86.6 61.9-95.8
Tumors of the pituitary Childrene (0-14) 424 99.8 98.1-100.0 99.5 97.7-99.9 98.7 96.0-99.6 98.7 96.0-99.6
AYAf (15-39) 11,152 99.6 99.4-99.7 99.5 99.3-99.7 99.2 98.9-99.4 98.4 97.7-98.9
Adults (40+) 24,505 97.2 96.9-97.5 96.6 96.2-96.9 95.4 94.8-95.9 93.6 92.3-94.7
Craniopharyngioma Childrene (0-14) 421 97.2 95.0-98.5 96.4 94.0-97.9 92.6 88.9-95.0 90.9 86.8-93.8
AYAf (15-39) 415 95.7 93.1-97.3 94.0 91.0-96.0 89.6 85.5-92.6 87.0 82.0-90.6
Adults (40+) 908 88.7 86.2-90.7 85.2 82.3-87.6 77.6 73.7-80.9 70.4 64.1-75.9
Hemangioma Childrene (0-14) 161 99.4 94.5-99.9 99.4 94.5-99.9 99.4 94.5-99.9 99.4 94.5-99.9
AYAf (15-39) 735 99.5 98.4-99.8 99.3 98.0-99.7 99.1 97.4-99.7 97.7 93.7-99.2
Adults (40+) 1,676 94.4 93.0-95.6 93.0 91.3-94.4 90.6 88.0-92.6 88.6 81.6-93.0
TOTAL: All Non- Malignant Brain and Other Nervous System g Children d (0-14) 3,230 98.4 97.9-98.8 98.0 97.4-98.4 96.6 95.8-97.3 94.9 93.3-96.1
AYA e (15-39) 23,272 99.1 99.0-99.2 98.8 98.6-98.9 97.9 97.6-98.1 96.5 96.0-97.0
Adults (40+) 118,091 93.4 93.2-93.5 91.9 91.7-92.1 89.1 88.7-89.4 85.2 84.5-85.9

**Confidence interval could not be calculated.

aThe cohort analysis of survival rates was utilized for calculating the survival estimates presented in this table. Long-term cohort-based survival estimates reflect the survival experience of individuals diagnosed over the time period, and they may not necessarily reflect the long-term survival outlook of newly diagnosed cases.

bRates are an estimate of the percentage of patients alive at one, two, five, and ten years, respectively. Rates were not presented for categories with 50 or less cases and were suppressed for rates where less than 16 cases were surviving within a category.

cEstimated by CBTRUS using Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2015 Sub (2000-2014) <Katrina/Rita Population Adjustment> - Linked To County Attributes - Total U.S., 1969-2015 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2017, based on the November 2016 submission.

dTotal number of case that occurred within the SEER registries between 2004 and 2014.

eChildren as defined by the National Cancer Institute, see: http://www.cancer.gov/researchandfunding/snapshots/pediatric.

fAdolescents and Young Adults (AYA), as defined by the National Cancer Institute, see: http://www.cancer.gov/researchandfunding/snapshots/adolescent-young-adult.

gTotal includes histologies not listed in this table.

Abbreviation: SEER, Survival, Epidemiology, and End Results; CI, confidence interval; NOS, not otherwise specified.